Opaleye Management Inc., 10% Owner at Grace Therapeutics, Inc. (GRCE), bought 15,089 shares at $2.10 ($32K) on 2026-09-21, disclosed to the SEC on 2026-09-23.
Open-market purchase of $32k GRCE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.10 | 9,771 | $21K | 64.8% |
| 2 | $2.10 | 5,318 | $11K | 35.2% |
| Total | $2.10 avg | 15,089 | $32K | 100% |
| Filing → |
| GRCE | BUY | 2026-10-01 | $16K | — | Filing → |
| ACOG | BUY | 2026-09-16 | $1.1M | — | Filing → |
| SLGL | BUY | 2026-09-14 | $207K | — | Filing → |